推荐产品
检测方案
95%
形式
solid
mp
179-183 °C (lit.)
SMILES字符串
OC(=O)Cc1ccc(CBr)cc1
InChI
1S/C9H9BrO2/c10-6-8-3-1-7(2-4-8)5-9(11)12/h1-4H,5-6H2,(H,11,12)
InChI key
WCOCCXZFEJGHTC-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
应用
丝氨酸蛋白酶抑制剂的前体。用于合成新型冠醚受体。
警示用语:
Danger
危险分类
Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
新产品
Bioorganic & medicinal chemistry letters, 19(8), 2270-2272 (2009-03-17)
We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as well as the in vitro and in vivo activities
Journal of the Chemical Society. Chemical Communications, 399-399 (1993)
Journal of medicinal chemistry, 35(23), 4297-4305 (1992-11-13)
Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katzenellenbogen, J.A. J. Med. Chem., submitted). In this study, we describe the synthesis and
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门